Changes in empowerment and anxiety of patients and parents during genetic counselling for epilepsy.


Journal

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
ISSN: 1532-2130
Titre abrégé: Eur J Paediatr Neurol
Pays: England
ID NLM: 9715169

Informations de publication

Date de publication:
May 2021
Historique:
received: 31 08 2020
revised: 26 03 2021
accepted: 28 03 2021
pubmed: 11 5 2021
medline: 29 6 2021
entrez: 10 5 2021
Statut: ppublish

Résumé

Genetic testing and counselling are increasingly important in epilepsy care, aiming at finding a diagnosis, understanding aetiology and improving treatment and outcome. The psychological impact of genetic counselling from patients' or parents' perspectives is, however, unknown. We studied the counselee-reported outcome of genetic counselling before and after genetic testing for epilepsy by evaluating empowerment - a key outcome goal of counselling reflecting cognitive, decisional and behavioural control, emotional regulation and hope - and anxiety. We asked patients or their parents (for those <16 years or intellectually disabled) referred for genetic testing for epilepsy in two university hospitals between June 2014 and 2017 to complete the same two questionnaires at three timepoints: before and after pre-test counselling and after post-test counselling. Empowerment was measured with the Genetic Counselling Outcome Scale (GCOS-18); anxiety with the short State Trait Anxiety Inventory (STAI-6). A total of 63 participants (55 parents with the age of 29-66 years; 8 patients with the age of 21-42 years) were included in our study. Empowerment significantly increased during the genetic counselling trajectory with a medium effect size (p < 0.001, d = 0.57). A small but significant increase in empowerment was already seen after pre-test counselling (p = 0.038, d = 0.29). Anxiety did not change significantly during the counselling trajectory (p = 0.223, d = -0.24). Our study highlights that patients with epilepsy or their parents show a clinically relevant increase in empowerment after genetic counselling. Empowerment was already increased after pre-test counselling, suggesting the importance of counselling before initiating genetic testing for epilepsy. However, individual differences in changes in empowerment and anxiety were seen, suggesting that counselling could be further improved, based on individual needs.

Identifiants

pubmed: 33971557
pii: S1090-3798(21)00084-2
doi: 10.1016/j.ejpn.2021.03.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

128-135

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None of the authors have any conflicts of interest to disclose.

Auteurs

Danique R M Vlaskamp (DRM)

University of Groningen, University Medical Centre Groningen, Department of Genetics, Groningen, the Netherlands; University of Groningen, University Medical Centre Groningen, Department of Neurology, Groningen, the Netherlands.

Patrick Rump (P)

University of Groningen, University Medical Centre Groningen, Department of Genetics, Groningen, the Netherlands.

Petra M C Callenbach (PMC)

University of Groningen, University Medical Centre Groningen, Department of Neurology, Groningen, the Netherlands.

Eva H Brilstra (EH)

University Medical Centre Utrecht, Department of Genetics, Utrecht, the Netherlands.

Mary E Velthuizen (ME)

University Medical Centre Utrecht, Department of Genetics, Utrecht, the Netherlands.

Oebele F Brouwer (OF)

University of Groningen, University Medical Centre Groningen, Department of Neurology, Groningen, the Netherlands.

Adelita V Ranchor (AV)

University of Groningen, University Medical Centre Groningen, Department of Health Psychology, the Netherlands.

Conny M A van Ravenswaaij-Arts (CMA)

University of Groningen, University Medical Centre Groningen, Department of Genetics, Groningen, the Netherlands. Electronic address: c.m.a.van.ravenswaaij@umcg.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH